Overview
Mycolicibacterium fortuitum is a species of rapidly growing mycobacteria that was reclassified from the genus Mycobacterium to Mycolicibacterium based on genomic studies. It is widely distributed in the environment, particularly in soil and water, and is known for its resilience to standard disinfectants and antibiotics. The bacterium is an opportunistic pathogen, primarily affecting individuals with weakened immune systems or those exposed through medical procedures. In addition to its clinical significance, Mycolicibacterium fortuitum is studied for its role in biodegradation, particularly of hydrocarbons and other environmental pollutants. Its ability to form biofilms contributes to its persistence in both natural and man-made environments, making it a subject of interest in both medical and environmental microbiology.
Key Features
Mycolicibacterium fortuitum exhibits several distinctive features that set it apart from other mycobacteria. It grows rapidly, forming visible colonies within 2-7 days on standard culture media, unlike slow-growing mycobacteria such as Mycobacterium tuberculosis. The bacterium is also known for its resistance to many common disinfectants, including chlorhexidine and glutaraldehyde, which complicates infection control measures. Another key feature is its ability to form biofilms, which enhance its survival in harsh environments and on medical devices. This biofilm formation is a significant factor in nosocomial infections. Additionally, Mycolicibacterium fortuitum has demonstrated the capacity to degrade complex organic compounds, making it a candidate for bioremediation applications.
Application Areas
In clinical settings, Mycolicibacterium fortuitum is primarily recognized as a cause of opportunistic infections, including skin and soft tissue infections, catheter-related infections, and post-surgical infections. Diagnostic laboratories often identify it through culture and molecular methods, as it can be misidentified due to its rapid growth and atypical biochemical profiles. Beyond healthcare, this bacterium is studied for its environmental applications. Its hydrocarbon-degrading abilities make it useful in bioremediation projects aimed at cleaning up oil spills and other petroleum-contaminated sites. Researchers also investigate its metabolic pathways to develop new biotechnological tools for degrading persistent environmental pollutants.
Precautions
Handling Mycolicibacterium fortuitum requires biosafety level 2 (BSL-2) precautions to prevent laboratory-acquired infections. Proper personal protective equipment (PPE), including gloves and masks, should be used when working with cultures or clinical specimens. Disinfection protocols should include mycobactericidal agents, as standard disinfectants may be ineffective. In healthcare settings, preventing infections involves stringent sterilization of medical devices and monitoring water systems where the bacterium may proliferate. For patients with infections, treatment typically involves a combination of antibiotics, such as macrolides, fluoroquinolones, and aminoglycosides, often requiring prolonged courses due to the bacterium's inherent resistance.
B2B Procurement Guide
When procuring Mycolicibacterium fortuitum strains for research or clinical use, it is essential to source them from reputable culture collections, such as the American Type Culture Collection (ATCC) or the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ). These institutions provide well-documented strains with detailed metadata, ensuring reliability and traceability. Buyers should verify the strain's identification, growth characteristics, and any available antibiotic susceptibility data. For environmental applications, consider strains with proven biodegradation capabilities. Pricing varies depending on the strain and supplier, so request quotes from multiple vendors. Ensure compliance with local regulations regarding the import and use of pathogenic microorganisms.